Mumbai-based Haffkine Biopharma gets Rs 159 crore grant for vaccine production

Haffkine Biopharma has been allotted a grant of Rs 159 crore by the Centre and the Maharashtra government combined for the production of Covaxin doses.

Haffkine Bio Pharmaceutical Corporation Limited, a Maharashtra state Public Sector Undertakings [PSU], proposed to produce 22.8 crore doses of Covaxin in a year. The production will take place at the Parel complex of the company in Mumbai. Government agencies informed that for undertaking production of Covaxin, Haffkine Biopharma has been allotted a total grant of Rs 159 crore -- Rs 65 crore grant by the Centre and Rs 94 crore from the Maharashtra government. Haffkine Biopharma is a manufacturing Covaxin vaccine under technology transfer arrangement with Bharat Biotech Ltd, Hyderabad.